Buscar
Sophia Genetics SA
SOPHAñadir a la lista de seguimiento
7.860USD
-0.010-0.13%
Horarios del mercado 09/14, 15:25（ET）
669.10MCap. mercado
PérdidaP/E TTM
Más Datos de Sophia Genetics SA Compañía
SOPHiA GENETICS SA is a Switzerland-based company primarily engaged in the healthcare technology industry. The Company’s key product is SOPHiA DDM, which is a cloud-native software-as-a-service (SaaS) platform. The platform analyses multimodal data, including genomics, radiomics, clinical, biological, and digital pathology data, to generate actionable insights for patients with cancer or rare diseases, bringing the power of data-driven medicine to patients across the globe. Additionally, the Company aids BioPharma partners with artificial-intelligence-powered drug discovery, development, and deployment. The Company has offices in Switzerland, France, and the United States and operates worldwide.
Perfil de Sophia Genetics SA
Símbolo de cotizaciónSOPH
Nombre de la empresaSOPHiA GENETICS SA
Fecha de salida a bolsaJul 23, 2021
Director ejecutivoCamblong (Jurgi)
Número de empleados423
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 23
DirecciónLa Piece 12
CiudadROLLE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísSwitzerland
Código postalCH-1180
Teléfono41216941060
Sitio Webhttps://www.sophiagenetics.com/
Símbolo de cotizaciónSOPH
Fecha de salida a bolsaJul 23, 2021
Director ejecutivoCamblong (Jurgi)
Ejecutivos de Sophia Genetics SA
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Dr. Zhenyu Xu, Ph.D.
Dr. Zhenyu Xu, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
443.79K
-12.17%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
Mr. Troy M. Cox
Mr. Troy M. Cox
Independent Director
Independent Director
294.96K
+6.69%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Dr. Jurgi Camblong, Ph.D.
Dr. Jurgi Camblong, Ph.D.
Executive Chairman of the Board, Co-Founder
Executive Chairman of the Board, Co-Founder
2.82M
-1.72%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Mr. Ross J. Muken
Mr. Ross J. Muken
Chief Executive Officer, Director
Chief Executive Officer, Director
615.78K
-1.60%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Dr. Vincent Ossipow, Ph.D.
Dr. Vincent Ossipow, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
489.08K
+4.03%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Sophia Genetics SA?
Los cinco principales accionistas de Sophia Genetics SA son: Dr. Jurgi Camblong, Ph.D.
¿Cuántas instituciones poseen acciones de Sophia Genetics SA (SOPH)?
A fecha de 2026Q1, 89 instituciones poseen acciones de Sophia Genetics SA, con un valor de mercado combinado de aproximadamente 27.73M, lo que representa el 38.63% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -11894064.00.